Trial Profile
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution & Placebo (Nepafenac Vehicle) for the Prevention & Treatment of Ocular Inflammation & Ocular Pain Associated with Cataract Surgery. European Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary) ; Ketorolac
- Indications Ocular inflammation; Ocular pain
- Focus Registrational; Therapeutic Use
- Sponsors Alcon
- 13 Dec 2018 New trial record